Izun Pharmaceuticals Overview
Izun Pharmaceuticals Corporation focuses on natural solutions in the area of periodontal inflammation. Izuns products are both efficacious and safe, providing novel solutions with the potential to capitalize on multi-billion-dollar market opportunities. Izun Pharma Ltd is a wholly-owned Jerusalem-based R&D subsidiary. A proprietary, botanically-based platform technology was developed which helps treat a wide range of inflammatory diseases, while simultaneously accelerating the bodys natural tissue repair processes.
Latest News
Team Members
1
Employees: 1-10
Web & Social Links
| Website | www.izunpharma.com/ |
Locations
Kiryat HaMada 5, Jerusalem, Israel
1 Rockefeller Plaza, New York, NY 10020, USA
Photos & Videos
No files yet
Izun Pharmaceuticals Business
Sector
—Target Customer
—Core Technology
—Tags (4)
tissue-regenerationinflammatory-diseasestopical-treatmentpharmaceuticalsIzun Pharmaceuticals Financials
Izun Pharmaceuticals Lifecycle
Izun Pharmaceuticals News
1 articleIzun Pharmaceuticals Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 6 |
| Team members | 1 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
Izun Pharmaceuticals Internal
Recent Updates
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 57/100 |
| Missing | funding stage, product stage, sector, founding month, business model, video or image, funding rounds, markets, not claimed |
| BI Verification | Yamila Silbert |
| Phone | +972722458950 |
| Creator | Yanina Wainscheinker |
| Creator email | yanina.wain@gmail.com |
| Last updater | Maor Perlov |
| Updater email | maor.perlov@sncentral.org |
| Last update | 2022-11-29T00:00:00.000Z |
| Created | 2019-04-03T00:00:00.000Z |